g10 fx
Chugai returned emugrobart rights and Chugai Pharmaceutical stock costs EUR 34.54 - AD HOC NEWS
From the original
Chugai returned emugrobart rights and Chugai Pharmaceutical stock costs EUR 34.54 AD HOC NEWS
Related speeches
4 itemsCiti keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00 - AD HOC NEWS
Mizuho Financial Group lifts outlook as Mizuho Financial Group stock trades EUR 9.70 versus EUR 9.65 - AD HOC NEWS
Barclays upgrades Givaudan stock to Buy at CHF 3,850.00 - AD HOC NEWS
Barclays raises target for Givaudan stock to CHF 3,850.00 - AD HOC NEWS
More like this
5 itemsJPMorgan previews Japan's IT services and telecom earnings season: Cybersecurity takes center stage, while overlooked stocks await a rebound - Moomoo
Citi keeps Buy rating for Chugai Pharmaceutical stock at JPY 11,100.00 - AD HOC NEWS
Equities: AI concerns pressure stocks as futures rise – Deutsche Bank - www.tmgm.com
Equities: Bond stress triggers global stock retreat - Deutsche Bank - www.tmgm.com